C21 Investments Inc. (CXXI.CN)
CAD 0.28
(3.77%)
CAD 0.28
(3.77%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 28.28 Million USD | -2.09% |
| 2022 | 28.88 Million USD | -12.41% |
| 2021 | 32.98 Million USD | -8.7% |
| 2020 | 36.12 Million USD | -4.18% |
| 2019 | 37.7 Million USD | 1358.32% |
| 2018 | 2.58 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | -100.0% |
| 2011 | 132.34 Thousand USD | -7.32% |
| 2010 | 142.8 Thousand USD | 2.4% |
| 2009 | 139.44 Thousand USD | -44.04% |
| 2008 | 249.19 Thousand USD | 127.65% |
| 2007 | 109.46 Thousand USD | 219.28% |
| 2006 | 34.28 Thousand USD | 20.4% |
| 2005 | 28.47 Thousand USD | 217.66% |
| 2004 | 8964.57 USD | -66.76% |
| 2003 | 26.96 Thousand USD | 1055.95% |
| 2002 | 2333.06 USD | -70.98% |
| 2001 | 8039.53 USD | 46.14% |
| 2000 | 5501.35 USD | -84.37% |
| 1999 | 35.2 Thousand USD | -59.28% |
| 1998 | 86.45 Thousand USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 6.59 Million USD | 0.0% |
| 2023 Q1 | 7.69 Million USD | 9.37% |
| 2023 FY | 28.28 Million USD | -2.09% |
| 2023 Q4 | 6.54 Million USD | -4.84% |
| 2023 Q3 | 6.88 Million USD | -3.91% |
| 2023 Q2 | 7.16 Million USD | -6.89% |
| 2022 Q3 | 7.2 Million USD | 0.44% |
| 2022 Q4 | 7.03 Million USD | -2.42% |
| 2022 FY | 28.88 Million USD | -12.41% |
| 2022 Q2 | 7.17 Million USD | -3.97% |
| 2022 Q1 | 7.47 Million USD | 11.52% |
| 2021 Q4 | 6.7 Million USD | -17.85% |
| 2021 FY | 32.98 Million USD | -8.7% |
| 2021 Q1 | 9.15 Million USD | 0.05% |
| 2021 Q2 | 8.97 Million USD | -1.91% |
| 2021 Q3 | 8.15 Million USD | -9.13% |
| 2020 FY | 36.12 Million USD | -4.18% |
| 2020 Q1 | 8.14 Million USD | -14.36% |
| 2020 Q2 | 9.36 Million USD | 14.98% |
| 2020 Q3 | 9.46 Million USD | 1.1% |
| 2020 Q4 | 9.14 Million USD | -3.41% |
| 2019 Q1 | 7.75 Million USD | 255.66% |
| 2019 Q2 | 9.85 Million USD | 27.1% |
| 2019 Q3 | 10.57 Million USD | 7.27% |
| 2019 FY | 37.7 Million USD | 1358.32% |
| 2019 Q4 | 9.51 Million USD | -10.06% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q4 | 2.18 Million USD | 629.13% |
| 2018 Q3 | 299.12 Thousand USD | 181.88% |
| 2018 Q2 | 106.11 Thousand USD | 0.0% |
| 2018 FY | 2.58 Million USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 100.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2012 Q1 | 3433.34 USD | -86.72% |
| 2012 FY | - USD | -100.0% |
| 2012 Q4 | -21.32 Thousand USD | -3254.14% |
| 2012 Q2 | 17.24 Thousand USD | 402.28% |
| 2012 Q3 | 676.14 USD | -96.08% |
| 2011 FY | 132.34 Thousand USD | -7.32% |
| 2011 Q1 | 48.48 Thousand USD | -16.45% |
| 2011 Q2 | 37.26 Thousand USD | -23.15% |
| 2011 Q3 | 24.63 Thousand USD | -33.9% |
| 2011 Q4 | 25.85 Thousand USD | 4.95% |
| 2010 Q2 | 31.92 Thousand USD | 72.72% |
| 2010 Q3 | 34.29 Thousand USD | 7.39% |
| 2010 Q4 | 58.03 Thousand USD | 69.26% |
| 2010 FY | 142.8 Thousand USD | 2.4% |
| 2010 Q1 | 18.48 Thousand USD | -69.91% |
| 2009 Q2 | 18.25 Thousand USD | -5.59% |
| 2009 FY | 139.44 Thousand USD | -44.04% |
| 2009 Q4 | 61.44 Thousand USD | 59.82% |
| 2009 Q1 | 19.33 Thousand USD | 140.33% |
| 2009 Q3 | 38.44 Thousand USD | 110.58% |
| 2008 FY | 249.19 Thousand USD | 127.65% |
| 2008 Q4 | 8046.83 USD | -93.0% |
| 2008 Q3 | 114.87 Thousand USD | 7.55% |
| 2008 Q2 | 106.81 Thousand USD | 157.0% |
| 2008 Q1 | 41.56 Thousand USD | 53.2% |
| 2007 Q2 | 30.15 Thousand USD | 125.45% |
| 2007 Q4 | 27.12 Thousand USD | -17.74% |
| 2007 Q3 | 32.97 Thousand USD | 9.37% |
| 2007 FY | 109.46 Thousand USD | 219.28% |
| 2007 Q1 | 13.37 Thousand USD | 502.35% |
| 2006 Q3 | 13.09 Thousand USD | 35.98% |
| 2006 Q2 | 9630.06 USD | 3.58% |
| 2006 Q1 | 9297.54 USD | -46.53% |
| 2006 FY | 34.28 Thousand USD | 20.4% |
| 2006 Q4 | 2220.29 USD | -83.04% |
| 2005 Q4 | 17.38 Thousand USD | 62.94% |
| 2005 Q3 | 10.67 Thousand USD | 12213.93% |
| 2005 Q2 | 86.66 USD | -54.45% |
| 2005 Q1 | 190.26 USD | -93.73% |
| 2005 FY | 28.47 Thousand USD | 217.66% |
| 2004 Q4 | 3035.02 USD | 146.4% |
| 2004 Q1 | 1374.52 USD | -87.85% |
| 2004 Q2 | 2882.38 USD | 109.7% |
| 2004 FY | 8964.57 USD | -66.76% |
| 2004 Q3 | 1231.73 USD | -57.27% |
| 2003 Q1 | 1301.30 USD | 107.48% |
| 2003 Q2 | 3022.15 USD | 132.24% |
| 2003 Q3 | 11.02 Thousand USD | 264.84% |
| 2003 FY | 26.96 Thousand USD | 1055.95% |
| 2003 Q4 | 11.31 Thousand USD | 2.61% |
| 2002 Q2 | 943.87 USD | 50.28% |
| 2002 Q1 | 628.08 USD | 114.33% |
| 2002 FY | 2333.06 USD | -70.98% |
| 2002 Q4 | 627.18 USD | 446.15% |
| 2002 Q3 | 114.84 USD | -87.83% |
| 2001 FY | 8039.53 USD | 46.14% |
| 2001 Q4 | -4384.22 USD | -180.6% |
| 2001 Q3 | 5439.25 USD | -1.49% |
| 2001 Q2 | 5521.38 USD | 221.8% |
| 2001 Q1 | 1715.78 USD | 285.2% |
| 2000 Q4 | -926.44 USD | -194.9% |
| 2000 Q3 | 976.22 USD | 0.0% |
| 2000 FY | 5501.35 USD | -84.37% |
| 2000 Q1 | 7678.02 USD | 3280.85% |
| 2000 Q2 | - USD | -100.0% |
| 1999 Q4 | -241.38 USD | -108.17% |
| 1999 Q2 | 19.36 Thousand USD | 51.54% |
| 1999 FY | 35.2 Thousand USD | -59.28% |
| 1999 Q1 | 12.78 Thousand USD | 0.0% |
| 1999 Q3 | 2955.93 USD | -84.74% |
| 1998 FY | 86.45 Thousand USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aion Therapeutic Inc. | 367.47 Thousand CAD | -7597.093% |
| Ayurcann Holdings Corp. | 25.15 Million CAD | -12.432% |
| Blueberries Medical Corp. | 288.27 Thousand CAD | -9711.983% |
| The BC Bud Corporation | 61.48 Thousand CAD | -45905.66% |
| BioNxt Solutions Inc. | 372.24 Thousand CAD | -7498.503% |
| CordovaCann Corp. | 13.59 Million CAD | -108.06% |
| Christina Lake Cannabis Corp. | 11.77 Million CAD | -140.118% |
| Captor Capital Corp. | 36.76 Million CAD | 23.067% |
| City View Green Holdings Inc. | 8582.00 CAD | -329487.509% |
| 1CM Inc. | 35.34 Million CAD | 19.966% |
| Global Hemp Group Inc. | - CAD | -Infinity% |
| Greenway Greenhouse Cannabis Corporation | 5.23 Million CAD | -440.806% |
| IM Cannabis Corp. | 48.8 Million CAD | 42.043% |
| Lobe Sciences Ltd. | 840.53 Thousand CAD | -3265.146% |
| Maple Leaf Green World Inc. | - CAD | -Infinity% |
| Mountain Valley MD Holdings Inc. | 60 Thousand CAD | -47042.0% |
| Nextleaf Solutions Ltd. | 8.17 Million CAD | -245.801% |
| Ovation Science Inc. | 61.93 Thousand CAD | -45569.907% |
| Pharmadrug Inc. | - CAD | -Infinity% |
| Captiva Verde Wellness Corp. | 174.78 Thousand CAD | -16082.668% |
| RAMM Pharma Corp. | 5.06 Million CAD | -458.415% |
| RIV Capital Inc. | 7.48 Million CAD | -277.737% |
| Revive Therapeutics Ltd. | - CAD | -Infinity% |
| Red White & Bloom Brands Inc. | 88.33 Million CAD | 67.979% |
| SLANG Worldwide Inc. | 35.68 Million CAD | 20.73% |
| 1933 Industries Inc. | 18.27 Million CAD | -54.79% |
| Red Light Holland Corp. | 4.75 Million CAD | -495.23% |
| Top Strike Resources Corp. | 13.32 Million CAD | -112.235% |
| Xebra Brands Ltd. | 106.85 Thousand CAD | -26370.638% |
| Adastra Holdings Ltd. | 22.22 Million CAD | -27.281% |